Annoying they seem to be backing away from reaching target PCA multiple. Most annoying because the CEO remuneration based on ROE based on theoretical target regulatory capital which they never actually teach.
also they are reducing reinsurance to lower PCA rather multiple rather than paying out capital.
they are trying to hold on to cash for when rates fall and new business picks up.
Ann: 2023 Full Year Results Investor Presentation, page-2
Add HLI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.00 |
Change
-0.050(1.23%) |
Mkt cap ! $1.168B | |||
| Open | High | Low | Value | Volume |
| $4.04 | $4.06 | $3.99 | $2.070M | 516.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3383 | $3.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.01 | 1563 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.01 |
Change
-0.050 ( 1.11 %) |
||||
| Open | High | Low | Volume | ||
| $4.04 | $4.05 | $3.99 | 116336 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| HLI (ASX) Chart |